Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_assertion type Assertion NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_head.
- NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_assertion description "[PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_provenance.
- NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_assertion evidence source_evidence_literature NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_provenance.
- NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_assertion SIO_000772 17721278 NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_provenance.
- NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_assertion wasDerivedFrom befree-2016 NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_provenance.
- NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_assertion wasGeneratedBy ECO_0000203 NP626695.RAo6casvw52WCyeqECkRGkIO39-QTNtSI7gLz7M5F1T7U130_provenance.